These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8748888)

  • 1. Intravital capillaroscopy in patients with chronic venous insufficiency and lymphoedema: relevance to Daflon 500 mg.
    Bollinger A; Herrig I; Fischer M; Hoffmann U; Franzeck UK
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():41-4. PubMed ID: 8748888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).
    Franzeck UK; Haselbach P; Speiser D; Bollinger A
    Yale J Biol Med; 1993; 66(1):37-46. PubMed ID: 8256463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An original microhaemorheological approach to the pharmacological effects of Daflon 500 mg in severe chronic venous insufficiency.
    Allegra C; Bartolo M; Carioti B; Cassiani D
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():50-4. PubMed ID: 8748890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
    Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microangiopathies in chronic venous insufficiency (CVI)].
    Leu AJ; Franzeck UK; Bollinger A
    Ther Umsch; 1991 Oct; 48(10):715-21. PubMed ID: 1780801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
    Struckmann JR; Nicolaides AN
    Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of cutaneous microangiopathy for the pathogenesis of dermatitis in venous congestion due to chronic venous insufficiency].
    Jünger M; Hahn U; Bort S; Klyscz T; Hahn M; Rassner G
    Wien Med Wochenschr; 1994; 144(10-11):206-10. PubMed ID: 7856186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular changes in chronic venous insufficiency--a review.
    Leu AJ; Leu HJ; Franzeck UK; Bollinger A
    Cardiovasc Surg; 1995 Jun; 3(3):237-45. PubMed ID: 7655836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
    Guillot B
    Angiology; 1994 Jun; 45(6 Pt 2):542-8. PubMed ID: 8203785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microangiopathy in mild chronic venous incompetence (CVI): morphological alterations and increased transcapillary diffusion detected by fluorescence videomicroscopy.
    Speiser DE; Bollinger A
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):55-66. PubMed ID: 2019484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
    Angiology; 1994 Jun; 45(6 Pt 2):493-584. PubMed ID: 7911285
    [No Abstract]   [Full Text] [Related]  

  • 13. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
    Jünger M; Steins A; Hahn M; Häfner HM
    Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular changes in venous disease: an update.
    Bollinger A; Leu AJ; Hoffmann U; Franzeck UK
    Angiology; 1997 Jan; 48(1):27-32. PubMed ID: 8995340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
    Hnátek L
    Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous microcirculation in skin lesions associated with chronic venous insufficiency.
    Stücker M; Schöbe MC; Hoffmann K; Schultz-Ehrenburg U
    Dermatol Surg; 1995 Oct; 21(10):877-82. PubMed ID: 7551745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
    Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg.
    Bergan JJ; Schmid-Schönbein GW; Takase S
    Angiology; 2001 Aug; 52 Suppl 1():S43-7. PubMed ID: 11510596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microangiopathy in chronic venous insufficiency].
    Leu AJ; Yanar A; Pfister G; Geiger M; Franzeck UK; Bollinger A
    Dtsch Med Wochenschr; 1991 Mar; 116(12):447-53. PubMed ID: 2004586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.